中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
自动化研究所 [2]
合肥物质科学研究院 [2]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2023 [1]
2022 [1]
2020 [1]
2012 [1]
学科主题
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study
期刊论文
OAI收割
BMC MEDICINE, 2023, 卷号: 21, 期号: 1, 页码: 13
作者:
Liu, Ting
;
Dong, Di
;
Zhao, Xun
;
Ou, Xiao-Min
;
Yi, Jun-Lin
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2024/02/22
Recurrent nasopharyngeal carcinoma
Re-radiotherapy
Nasopharyngeal necrosis
Radiomics
Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma
期刊论文
OAI收割
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 页码: 11
作者:
Zhao, Xun
;
Liang, Yu-Jing
;
Zhang, Xu
;
Wen, Dong-Xiang
;
Fan, Wei
  |  
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2022/06/10
Recurrent nasopharyngeal carcinoma
Survival analysis
Radiomics
Deep learning
Apatinib in treating patients with recurrent or metastatic nasopharyngeal carcinoma who had failed prior platinum-based chemotherapy
期刊论文
OAI收割
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:
Tao, Chan-Juan
;
Zhang, Peng
;
Zhou, Ling
;
Hu, Qiao-Ying
;
Chen, Xiao-Zhong
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2020/12/28
Apatinib
nasopharyngeal carcinoma (NPC)
recurrent or metastatic
platinum-based chemotherapy
toxicity
Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy
期刊论文
OAI收割
CHINESE MEDICAL JOURNAL, 2012, 卷号: 125
作者:
Liu Feng
;
Xiao Jianping
;
Xu Yingjie
;
Zhang Ye
;
Xu Guozhen
  |  
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2020/10/26
RADIOSURGICAL BOOST
RECURRENT
PERSISTENT
SALVAGE
BRACHYTHERAPY
SURVIVAL
FAILURES
nasopharyngeal carcinoma
residual lesions
stereotactic radiotherapy
boost irradiation